OpenURL Connection Search

Select item for more details and to access through your institution.

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1376622
By:
- Lopez, Diana C.;
- Fabian, Kellsye P.;
- Padget, Michelle R.;
- Robbins, Yvette L.;
- Kowalczyk, Joshua T.;
- Lassoued, Wiem;
- Pastor, Danielle M.;
- Allen, Clint T.;
- Gallia, Gary L.;
- Gulley, James L.;
- Hodge, James W.;
- London Jr., Nyall R.
Publication type:
Article
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45902-y
By:
- Kim, Yong Yean;
- Gryder, Berkley E.;
- Sinniah, Ranuka;
- Peach, Megan L.;
- Shern, Jack F.;
- Abdelmaksoud, Abdalla;
- Pomella, Silvia;
- Woldemichael, Girma M.;
- Stanton, Benjamin Z.;
- Milewski, David;
- Barchi Jr., Joseph J.;
- Schneekloth Jr, John S.;
- Chari, Raj;
- Kowalczyk, Joshua T.;
- Shenoy, Shilpa R.;
- Evans, Jason R.;
- Song, Young K.;
- Wang, Chaoyu;
- Wen, Xinyu;
- Chou, Hsien-Chao
Publication type:
Article
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.
Published in:
Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2783, doi. 10.1007/s00262-023-03459-7
By:
- Franks, S. Elizabeth;
- Santiago-Sanchez, Ginette S.;
- Fabian, Kellsye P.;
- Solocinski, Kristen;
- Chariou, Paul L.;
- Hamilton, Duane H.;
- Kowalczyk, Joshua T.;
- Padget, Michelle R.;
- Gameiro, Sofia R.;
- Schlom, Jeffrey;
- Hodge, James W.
Publication type:
Article
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.
Published in:
Cancers, 2024, v. 16, n. 13, p. 2320, doi. 10.3390/cancers16132320
By:
- Stauffer, Stacey;
- Roth, Jacob S.;
- Hernandez, Edjay R.;
- Kowalczyk, Joshua T.;
- Sealover, Nancy E.;
- Hebron, Katie E.;
- James, Amy;
- Isanogle, Kristine A.;
- Riffle, Lisa A.;
- Ileva, Lilia;
- Luo, Xiaoling;
- Chen, Jin-Qiu;
- Kedei, Noemi;
- Kortum, Robert L.;
- Lei, Haiyan;
- Shern, Jack F.;
- Kalen, Joseph D.;
- Edmondson, Elijah F.;
- Hall, Matthew D.;
- Difilippantonio, Simone
Publication type:
Article
Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation.
Published in:
Cells (2073-4409), 2022, v. 11, n. 23, p. 3826, doi. 10.3390/cells11233826
By:
- Fabian, Kellsye P.;
- Kowalczyk, Joshua T.;
- Reynolds, Sandy T.;
- Hodge, James W.
Publication type:
Article
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1012058
By:
- Lopez, Diana C.;
- Robbins, Yvette L.;
- Kowalczyk, Joshua T.;
- Lassoued, Wiem;
- Gulley, James L.;
- Miettinen, Markku M.;
- Gallia, Gary L.;
- Allen, Clint T.;
- Hodge, James W.;
- London Jr, Nyall R.
Publication type:
Article

Found: 6

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence.

KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.

Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.

Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation.

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.